BD 672210 - PowerLoc Safety Infusion Set with Y-Injection Site, 22G x 1", 20/PK (Continental US Only)

BD 672210 - PowerLoc Safety Infusion Set with Y-Injection Site, 22G x 1", 20/PK (Continental US Only)

The BD 2672210 PowerLoc PAK Safety Infusion Set is a sterile, single-use port-access solution designed for accessing compatible surgically implanted vascular ports. The set features a 22-gauge non-coring needle with a 1-inch length and includes a Y-injection site for secondary access to the infusion pathway.

The PowerLoc system provides a fluid pathway for administering compatible medications and solutions, withdrawing blood specimens, flushing implanted ports, and supporting approved contrast-media delivery through appropriately rated power-injectable vascular access systems. The 22-gauge configuration provides a smaller needle profile for therapies and procedures where moderate flow capability is appropriate.

The 1-inch needle length accommodates implanted ports positioned at a moderate depth beneath the skin. Proper needle-length selection helps support reliable septum access while maintaining stable positioning, effective dressing application, and appropriate patient comfort.

The integrated Y-injection site provides an additional access point within the tubing for compatible medication administration, flushing, or connection of another approved fluid pathway. The configuration includes approximately 8-inch tubing with an approximate 0.4 mL priming volume.

An integrated safety mechanism is designed to help reduce accidental needlestick exposure during port deaccessing. Following removal, the needle is secured within the protective mechanism to help cover the sharp point before handling and disposal.

The PAK presentation provides an organized solution intended to simplify the multi-step sterile port-access preparation process. BD 2672210 is supplied five sets per case.

Key Benefits

• 22-gauge non-coring needle supports access to compatible implanted vascular ports.
• One-inch needle length accommodates ports positioned at a moderate depth beneath the skin.
• Smaller 22-gauge profile may be suitable when moderate flow capability meets clinical requirements.
• Designed for compatible infusion therapy, medication administration, blood sampling, and implanted port maintenance.
• Y-injection site provides secondary access for compatible medication, flushing, or fluid administration.
• Approximately 8-inch tubing provides practical connection length for port-access procedures.
• Approximate 0.4 mL priming volume supports fluid-management planning.
• Non-coring needle design helps minimize unnecessary damage to the implanted port septum.
• Integrated safety mechanism helps protect the needle following port deaccessing.
• Safety lockout design supports occupational needlestick-prevention practices.
• Low-profile configuration supports dressing application and routine access-site management.
• Small footprint helps maintain visibility around the port-access site.
• Ergonomic wing design supports controlled access and site visibility.
• Downward-angled tubing helps support dressing integrity.
• Compatible with appropriate dual-lumen port applications.
• PAK format helps organize essential supplies used during sterile port-access preparation.
• Five-per-case packaging supports controlled clinical inventory management.

Compatibility and Applications

The BD 2672210 PowerLoc PAK Safety Infusion Set is intended for use with compatible surgically implanted vascular access ports designed to accept non-coring port-access needles.

Potential clinical applications include chemotherapy administration, antibiotic therapy, hydration, parenteral nutrition, blood specimen collection, implanted port flushing, long-term infusion therapy, and other compatible vascular-access procedures.

The 22-gauge needle may be selected when a smaller needle profile and moderate flow capability are appropriate for the prescribed therapy. Selection should consider medication or solution viscosity, desired flow rate, implanted port specifications, infusion-pump requirements, and professional clinical judgment.

The 1-inch needle length may be appropriate when a 0.75-inch needle does not provide sufficient depth but a 1.5-inch configuration would provide unnecessary additional length. Clinicians should assess tissue depth and port position before selecting the access needle.

The Y-injection site provides a secondary access point within the tubing. It may support compatible intermittent medication administration, flushing, or connection of an additional approved fluid pathway when permitted by the prescribed therapy and institutional protocol.

When used in a power-injection procedure, the implanted port, access needle, tubing, connectors, Y-injection site, and every other component within the fluid pathway must be approved for the intended operating conditions. The lowest-rated component determines the maximum allowable pressure and flow rate.

Compatibility should be confirmed with the exact implanted port model, septum design, port depth, prescribed therapy, infusion pump, connector system, dressing materials, and institutional vascular-access procedures.

Usage Guidelines

The BD 2672210 should be used only by healthcare professionals trained and authorized to access implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional procedures, and the implanted port manufacturer's directions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, and implanted port type.
• Assess the location and depth of the implanted port before selecting the 1-inch needle.
• Verify that the 22-gauge configuration provides adequate flow capability for the intended therapy.
• Confirm that the Y-injection site configuration is appropriate for the planned clinical workflow.
• Inspect the sterile package for punctures, moisture, damage, contamination, or compromised integrity.
• Prepare the implanted port site according to institutional antisepsis and sterile-access procedures.
• Prime the primary tubing and any intended secondary fluid pathway completely with an approved solution.
• Remove air from the complete fluid pathway before accessing the implanted port.
• Stabilize the port and insert the non-coring needle perpendicular to the septum using an approved technique.
• Advance the needle carefully until appropriate contact with the base of the port reservoir is achieved.
• Verify correct placement according to facility policy, including aspiration for blood return when clinically appropriate.
• Flush the implanted port according to current manufacturer instructions and institutional protocol.
• Position and secure the tubing to reduce pulling, twisting, pressure, and dressing disruption.
• Apply an approved sterile dressing and maintain appropriate access-site visualization.
• Disinfect the Y-injection site before each access according to facility protocol.
• Maintain aseptic technique whenever connecting to or manipulating the Y-injection site.
• Monitor the site for pain, swelling, redness, leakage, displacement, or other complications.
• After therapy, flush and lock the implanted port according to the prescribed protocol.
• Stabilize the port while withdrawing the needle and activating the safety mechanism.
• Confirm that the needle is secured in the protective position before handling.
• Dispose of the used device immediately in an approved sharps container.

Stop the procedure and assess the port-access system if resistance occurs during flushing, expected blood return cannot be obtained, the patient experiences unusual discomfort, or swelling, leakage, or another abnormality develops at the access site.

Certifications and Safety Standards

The BD 2672210 PowerLoc PAK Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, infection-prevention, and occupational safety programs.

The device should be incorporated into facility procedures covering implanted port assessment, sterile preparation, skin antisepsis, port access, infusion administration, connection management, dressing care, deaccessing, and sharps disposal.

The integrated safety mechanism is designed to help cover the needle point following removal from the implanted port. Audible and visual indication of lockout supports confirmation that the safety feature has been activated before final disposal.

The safety feature does not replace appropriate clinician training, personal protective equipment, safe sharps handling, exposure-control procedures, or immediate disposal in an approved sharps container.

The non-coring needle is intended to access the septum of a compatible implanted vascular port while helping minimize unnecessary septum damage when used correctly. Needle gauge and length should be selected according to patient anatomy, implanted port depth, prescribed therapy, required flow rate, and current manufacturer instructions.

Healthcare organizations should review current manufacturer documentation for applicable FDA clearance, UDI information, sterilization method, shelf life, material composition, natural rubber latex status, DEHP information, pressure limits, flow-rate specifications, and other technical or regulatory requirements.

Comparison with Competitors

Compared with conventional implanted port needles without integrated safety features, the BD PowerLoc system incorporates a protective mechanism designed to cover the needle point after deaccessing. This can help reduce accidental needlestick exposure between needle removal and final sharps disposal.

Compared with infusion sets without a Y-injection site, BD 2672210 provides a secondary access point within the tubing. This may support compatible intermittent medication administration or additional fluid connections without disconnecting the primary infusion pathway.

Compared with larger 19-gauge and 20-gauge port-access needles, the 22-gauge configuration provides a smaller needle profile. Larger-gauge alternatives may be preferred when higher flow requirements are clinically necessary.

Compared with a 0.75-inch access needle, the 1-inch configuration accommodates ports positioned at a greater depth beneath the skin. Compared with a 1.5-inch needle, it may provide a lower access profile when additional length is unnecessary.

Compared with loose individual port-access supplies, the PAK presentation organizes essential procedural components within one package. This can help simplify preparation and support consistency across clinicians and treatment environments.

Alternative safety infusion sets may vary in gauge, needle length, tubing configuration, Y-site design, safety mechanism, priming volume, included procedural components, and package quantity. BD 2672210 combines a 22-gauge, 1-inch non-coring needle with a Y-injection site, compact profile, safety lockout mechanism, and organized PAK presentation.

Typical User Profile and Application Scenarios

The BD 2672210 PowerLoc PAK Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, vascular-access specialists, physicians, advanced practice clinicians, radiology personnel, and other qualified healthcare professionals.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, ambulatory treatment centers, specialty practices, diagnostic departments, and other healthcare facilities where implanted vascular ports are routinely accessed.

The product may be selected for patients whose implanted port requires a 1-inch access needle and whose prescribed therapy is compatible with a 22-gauge device.

Typical application scenarios include medication infusion, antibiotic therapy, hydration, selected chemotherapy treatments, blood specimen collection, routine implanted port flushing, and other compatible long-term vascular-access procedures.

The Y-injection site is particularly useful in workflows requiring secondary access for compatible intermittent medication administration, flushing, or connection of another approved fluid pathway.

Best Practices for Use and Maintenance

The BD 2672210 is a sterile, single-use medical device and does not require maintenance as reusable equipment. Best practices focus on correct storage, product selection, sterile preparation, port-access technique, Y-site management, site monitoring, safety activation, and disposal.

• Store unopened sets according to manufacturer-recommended environmental conditions.
• Protect packages from moisture, excessive heat, freezing, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the BD 2672210 catalog number before opening the package.
• Confirm the 22-gauge size, 1-inch needle length, and presence of the Y-injection site.
• Assess the patient's tissue depth and implanted port position before selecting the needle length.
• Confirm that the required therapy and flow characteristics are appropriate for a 22-gauge device.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime all intended fluid pathways completely before accessing the implanted port.
• Stabilize the port during both needle insertion and removal.
• Position the tubing to avoid unnecessary pulling, twisting, or pressure at the access site.
• Scrub and disinfect the Y-injection site before each access according to institutional policy.
• Keep unused access points capped and protected from contamination.
• Monitor the port site and tubing connections throughout therapy.
• Do not bend, cut, modify, repair, or otherwise alter the infusion set.
• Do not reuse, clean, resterilize, or reprocess the single-use device.
• Confirm complete safety activation immediately after needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 2672210 PowerLoc PAK Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, professional clinical judgment, and institutional policy.

Before use, verify the product identity, 22-gauge size, 1-inch needle length, Y-injection site configuration, sterile package integrity, expiration date, and compatibility with the implanted vascular port. Do not use a device that is expired, damaged, contaminated, or supplied in compromised packaging.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may cause infiltration, extravasation, tissue injury, leakage, implanted port damage, interrupted therapy, or other complications.

The Y-injection site should be accessed only with compatible devices using appropriate disinfection and aseptic technique. Improper manipulation or inadequate disinfection may increase the risk of contamination, connection failure, or bloodstream infection.

For any power-injection procedure, clinicians should verify that the implanted port and all connected components are specifically approved for the intended pressure and flow conditions before use.

The integrated safety mechanism should be activated according to current manufacturer instructions. The used device remains a contaminated sharp following deaccessing and must be discarded immediately in an approved sharps container.

The product is supplied five sets per case. Distributor listings identify this configuration as temperature sensitive and non-returnable. Purchasing personnel should confirm current availability, shipping eligibility, storage requirements, order quantity, and applicable return conditions before purchasing.

How to Order

Select the BD 2672210 - PowerLoc PAK Safety Infusion Set with Y-Injection Site, 22G x 1" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.